Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
CNBC Daily Open: With cooler-than-expected PCE, would the Fed’s dot plot have looked different?
Tags Novo Nordisk A/S Daily Open Inflation
From CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
Tags Health & Science Biotechnology Business
From CNBC.com News
Novo Nordisk shares plunge 22% after CagriSema obesity drug trial results
Tags Biotechnology Breaking News: Europe Breaking News: Markets
From CNBC.com News
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Tags Merck & Co Inc Health care industry Pfizer Inc
From CNBC.com News
Europe's economy faces a bumpy ride in 2025. Here are 5 things to watch
Tags Novo Nordisk A/S Economy BE Semiconductor Industries NV
From CNBC.com News
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
Tags Health & Science Social issues Science
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
Tags Social issues Health & Science LILLY DRN
From CNBC.com News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
Tags Amazon/com Inc Business News Pharmaceuticals
From CNBC.com News
The weight-loss drug boom has become one of the internet's biggest scams
Tags Hims & Hers Health Inc Weight management Technology
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags Social issues GE HealthCare Technologies Inc Amgen Inc
From CNBC.com News
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
Tags US: News LILLY DRN Biotechnology
From CNBC.com News
Hiccups in ETFs tracking MicroStrategy occurring as bull market fuels trading boom in single-stock funds
Tags Markets Investment strategy Breaking News: Investing
From CNBC.com News
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
Tags Biotechnology Companies Business
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags 5 Things to Know Amgen Inc Markets
From CNBC.com News
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
Tags Breaking News: Business Business News Novo Nordisk A/S
From CNBC.com News
Amgen stock falls as analysts mull over weight loss drug’s bone density data
Tags Business News Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Tags LILLY DRN Viking Therapeutics Inc Social issues
From CNBC.com News
Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
Tags Health care industry Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
Tags Health care industry Breaking news Companies
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
Tags Science LILLY DRN Medical research
From CNBC.com News
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
Tickers HIMS LLY NEWS NVO
Tags HIMS General semaglutide
From Benzinga
Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
Tags Healthy Returns Amazon/com Inc Microsoft Corp
From CNBC.com News
Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
Tags LILLY DRN US: News Health & Science
From CNBC.com News
Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health care industry
From CNBC.com News
Cramer's Lightning Round: Uranium Energy is 'the real deal'
Tags stocks Business News Novo Nordisk A/S
From CNBC.com News
Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
Tags LILLY DRN Zealand Pharma A/S Biotechnology
From CNBC.com News
Ozempic underworld: Inside the black market of obesity drugs
Tags Business News Crime Novo Nordisk A/S
From CNBC.com News
CNBC Daily Open: October’s gravity bringing stocks down
Tickers JOBS OIL
Tags World Markets Europe Markets Markets
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
Tags Valero Energy Corp Constellation Energy Corp Hims & Hers Health Inc
From CNBC.com News
Port strike fallout: Blockbuster weight-loss drug supply from Wegovy to Ozempic, Mounjaro, Zepbound caught up in East Coast trade shutdown
Tags Labor issues Marine Ports and Services State of Freight
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.